We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
(+18%)
Cap. Flow
+$2.78B
Cap. Flow
% of AUM
12.74%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$363M |
| 2 |
Tencent Music
TME
|
+$184M |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$182M |
| 4 |
Baidu
BIDU
|
+$146M |
| 5 |
Gaotu Techedu
GOTU
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$204M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$189M |
| 3 |
Zoetis
ZTS
|
+$182M |
| 4 |
Guardant Health
GH
|
+$136M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Consumer Discretionary | 13.15% |
| 3 | Technology | 10.68% |
| 4 | Financials | 9.81% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Weyerhaeuser
WY
$17.7B
| $420K | ﹤0.01% |
+11,798
| New | +$402K |
|
|
CBPO
2002
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $420K | ﹤0.01% |
3,543
-27,337
| -89% | -$3.23M |
|
|
FPI
2003
Farmland Partners
FPI
$417M
| $419K | ﹤0.01% |
37,400
+24,258
| +185% | +$276K |
|
2004
CALL
MetLife
MET
$62.7B
| $419K | ﹤0.01% |
+6,900
| New | +$381K |
|
|
ABST
2005
DELISTED
Absolute Software Corp
ABST
| $418K | ﹤0.01% |
30,119
-248,104
| -89% | -$3.5M |
|
2006
CLPS Inc
CLPS
$24.5M
| $417K | ﹤0.01% |
82,210
+64,659
| +368% | +$303K |
|
2007
W.W. Grainger
GWW
$66B
| $414K | ﹤0.01% |
1,034
-5,386
| -84% | -$2.08M |
|
|
ARAV
2008
DELISTED
Aravive, Inc. Common Stock
ARAV
| $414K | ﹤0.01% |
62,810
+43,046
| +218% | +$283K |
|
|
IVAN.WS
2009
CALL
DELISTED
Ivanhoe Capital Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A
IVAN.WS
| $413K | ﹤0.01% |
+41,662
| New | +$65.9K |
|
2010
Mid-America Apartment Communities
MAA
$15.8B
| $410K | ﹤0.01% |
2,842
-380
| -12% | -$51.7K |
|
2011
Calix
CALX
$2.34B
| $409K | ﹤0.01% |
11,799
-15,851
| -57% | -$587K |
|
2012
Hurco Companies Inc
HURC
$135M
| $408K | ﹤0.01% |
+11,544
| New | +$373K |
|
2013
Innodata
INOD
$1.88B
| $408K | ﹤0.01% |
+64,800
| New | +$414K |
|
2014
Selective Insurance
SIGI
$5.63B
| $408K | ﹤0.01% |
+5,623
| New | +$391K |
|
|
RPT
2015
Rithm Property Trust
RPT
$95.8M
| $406K | ﹤0.01% |
+6,210
| New | +$411K |
|
2016
TriNet
TNET
$3.14B
| $404K | ﹤0.01% |
+5,188
| New | +$419K |
|
2017
Brookdale Senior Living
BKD
$3.67B
| $403K | ﹤0.01% |
+66,671
| New | +$359K |
|
2018
Citi Trends
CTRN
$559M
| $402K | ﹤0.01% |
+4,798
| New | +$342K |
|
2019
Safe Bulkers
SB
$761M
| $402K | ﹤0.01% |
+164,192
| New | +$387K |
|
2020
CrossAmerica Partners
CAPL
$839M
| $401K | ﹤0.01% |
+21,603
| New | +$394K |
|
2021
Milestone Scientific
MLSS
$38M
| $400K | ﹤0.01% |
+111,952
| New | +$384K |
|
|
OSH
2022
DELISTED
Oak Street Health, Inc.
OSH
| $398K | ﹤0.01% |
7,328
-16,560
| -69% | -$921K |
|
2023
Blackbaud
BLKB
$1.65B
| $397K | ﹤0.01% |
+5,585
| New | +$385K |
|
2024
OrthoPediatrics
KIDS
$510M
| $396K | ﹤0.01% |
8,133
+3,126
| +62% | +$150K |
|
2025
NOV
NOV
$7.11B
| $389K | ﹤0.01% |
28,344
-513,341
| -95% | -$7.45M |
|
Similar funds
Marshall Wace's Q1 2021 Portfolio in Review
As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.
- Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
- Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
- Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
- Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
- Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
- Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.
Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.